Oxford Pharmaceuticals, LLC

Oxford Pharmaceuticals is a manufacturer of generic oral solid tablets located in Birmingham, AL. Our new $30 million, state-of-the-art 150,000 sq. ft was FDA approved in 2019. Our engineering, quality control and process development, along with extensively experienced regulatory scientists ensures our control of product quality, safety, and efficacy standards. Our purpose is to provide quality products at competitive prices of our oral solid dose ANDAs through our cost-effective manufacturing capabilities. Manufacturing capabilities provide for the most current and efficient processes at large scale, and our automated Packaging Line Serialization meets 2023 requirements. The mezzanine warehouse has 25,000 sq. ft...

Packaging lines with serialization capability using optel / tracelink systems,multiple compression tablet presses,blending capacity from 3 cf to 150 cf blenders,coating system - accela cota,fluid bed granulator - 500 l vector system,11 compression rooms,4 coating rooms,two distribution warehouses,dea approved,in house label printing capability,on site qc+micro+r&d labs,walk in stability chambers,and high purity water system with distribution loop

Oxford pharmaceuticals, llc operates in the Pharmaceutical manufacturing industry.

Oxford pharmaceuticals, llc's revenue is 11m - 100m

Oxford pharmaceuticals, llc has 11 - 50 employees.